Lack of Data to Support ICI Retreatment in Advanced Melanoma
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it.
Source: oncologynurseadvisor.com
Stay updated with breaking news from Alpha Insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it.